Literature DB >> 24983796

The impact of symptom dimensions on outcome for exposure and ritual prevention therapy in obsessive-compulsive disorder.

Monnica T Williams1, Samantha G Farris2, Eric N Turkheimer3, Martin E Franklin2, H Blair Simpson4, Michael Liebowitz5, Edna B Foa2.   

Abstract

OBJECTIVE: Obsessive-compulsive disorder (OCD) is a severe condition with varied symptom presentations. The behavioral treatment with the most empirical support is exposure and ritual prevention (EX/RP). This study examined the impact of symptom dimensions on EX/RP outcomes in OCD patients.
METHOD: The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) was used to determine primary symptoms for each participant. An exploratory factor analysis (EFA) of 238 patients identified five dimensions: contamination/cleaning, doubts about harm/checking, hoarding, symmetry/ordering, and unacceptable/taboo thoughts (including religious/moral and somatic obsessions among others). A linear regression was conducted on those who had received EX/RP (n=87) to examine whether scores on the five symptom dimensions predicted post-treatment Y-BOCS scores, accounting for pre-treatment Y-BOCS scores.
RESULTS: The average reduction in Y-BOCS score was 43.0%, however the regression indicated that unacceptable/taboo thoughts (β=.27, p=.02) and hoarding dimensions (β=.23, p=.04) were associated with significantly poorer EX/RP treatment outcomes. Specifically, patients endorsing religious/moral obsessions, somatic concerns, and hoarding obsessions showed significantly smaller reductions in Y-BOCS severity scores.
CONCLUSIONS: EX/RP was effective for all symptom dimensions, however it was less effective for unacceptable/taboo thoughts and hoarding than for other dimensions. Clinical implications and directions for research are discussed.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Exposure and response prevention; Factor analysis; Hoarding; Obsessive-compulsive disorder; Symptom dimensions; Treatment outcome

Mesh:

Substances:

Year:  2014        PMID: 24983796      PMCID: PMC4151097          DOI: 10.1016/j.janxdis.2014.06.001

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  43 in total

1.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

2.  The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions.

Authors:  M C Rosario-Campos; E C Miguel; S Quatrano; P Chacon; Y Ferrao; D Findley; L Katsovich; L Scahill; R A King; S R Woody; D Tolin; E Hollander; Y Kano; J F Leckman
Journal:  Mol Psychiatry       Date:  2006-05       Impact factor: 15.992

Review 3.  Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V.

Authors:  James F Leckman; Damiaan Denys; H Blair Simpson; David Mataix-Cols; Eric Hollander; Sanjaya Saxena; Euripedes C Miguel; Scott L Rauch; Wayne K Goodman; Katharine A Phillips; Dan J Stein
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

4.  Symptoms of obsessive-compulsive disorder.

Authors:  J F Leckman; D E Grice; J Boardman; H Zhang; A Vitale; C Bondi; J Alsobrook; B S Peterson; D J Cohen; S A Rasmussen; W K Goodman; C J McDougle; D L Pauls
Journal:  Am J Psychiatry       Date:  1997-07       Impact factor: 18.112

5.  Sexual obsessions and clinical correlates in adults with obsessive-compulsive disorder.

Authors:  Jon E Grant; Anthony Pinto; Matthew Gunnip; Maria C Mancebo; Jane L Eisen; Steven A Rasmussen
Journal:  Compr Psychiatry       Date:  2006-04-21       Impact factor: 3.735

6.  Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.

Authors:  Edna B Foa; Michael R Liebowitz; Michael J Kozak; Sharon Davies; Rafael Campeas; Martin E Franklin; Jonathan D Huppert; Kevin Kjernisted; Vivienne Rowan; Andrew B Schmidt; H Blair Simpson; Xin Tu
Journal:  Am J Psychiatry       Date:  2005-01       Impact factor: 18.112

7.  Reliability and validity of the Yale-Brown Obsessive-Compulsive Scale.

Authors:  S R Woody; G Steketee; D L Chambless
Journal:  Behav Res Ther       Date:  1995-06

8.  Exposure and ritual prevention for obsessive-compulsive disorder: effects of intensive versus twice-weekly sessions.

Authors:  Jonathan S Abramowitz; Edna B Foa; Martin E Franklin
Journal:  J Consult Clin Psychol       Date:  2003-04

9.  Treatment of depressive and obsessive-compulsive symptoms in OCD by imipramine and behaviour therapy.

Authors:  E B Foa; M J Kozak; G S Steketee; P R McCarthy
Journal:  Br J Clin Psychol       Date:  1992-09

10.  Factor analysis of symptom subtypes of obsessive compulsive disorder and their relation to personality and tic disorders.

Authors:  L Baer
Journal:  J Clin Psychiatry       Date:  1994-03       Impact factor: 4.384

View more
  12 in total

1.  Effects of gender and executive function on visuospatial working memory in adult obsessive-compulsive disorder.

Authors:  Riccardo Maria Martoni; Giulia Salgari; Elisa Galimberti; Maria Cristina Cavallini; Joseph O'Neill
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-05-14       Impact factor: 5.270

2.  Distinguishing Fear Versus Distress Symptomatology in Pediatric OCD.

Authors:  Michelle Rozenman; Tara Peris; R Lindsey Bergman; Susanna Chang; Joseph O'Neill; James T McCracken; John Piacentini
Journal:  Child Psychiatry Hum Dev       Date:  2017-02

3.  Parental bonding and hoarding in obsessive-compulsive disorder.

Authors:  David Chen; O Joseph Bienvenu; Janice Krasnow; Ying Wang; Marco A Grados; Bernadette Cullen; Fernando S Goes; Brion Maher; Benjamin D Greenberg; Nicole C McLaughlin; Steven A Rasmussen; Abby J Fyer; James A Knowles; James T McCracken; John Piacentini; Dan Geller; David L Pauls; S Evelyn Stewart; Dennis L Murphy; Yin-Yao Shugart; Mark A Riddle; Gerald Nestadt; Jack Samuels
Journal:  Compr Psychiatry       Date:  2016-11-14       Impact factor: 3.735

4.  Diagnostic Differential Between Pedophilic-OCD and Pedophilic Disorder: An Illustration with Two Vignettes.

Authors:  Alexandra Bonagura; Dylan Abrams; Jonathan Teller
Journal:  Arch Sex Behav       Date:  2022-04-20

Review 5.  The prefrontal cortex and OCD.

Authors:  Susanne E Ahmari; Scott L Rauch
Journal:  Neuropsychopharmacology       Date:  2021-08-16       Impact factor: 7.853

6.  Demographic and health-related correlates of obsessive-compulsive symptoms among African Americans.

Authors:  Monnica T Williams; Robert Joseph Taylor; Joseph A Himle; Linda M Chatters
Journal:  J Obsessive Compuls Relat Disord       Date:  2017-07-08       Impact factor: 1.677

7.  REDUCED DISGUST PROPENSITY IS ASSOCIATED WITH IMPROVEMENT IN CONTAMINATION/WASHING SYMPTOMS IN OBSESSIVE-COMPULSIVE DISORDER.

Authors:  Alison J Athey; Jason A Elias; Jesse M Crosby; Michael A Jenike; Harrison G Pope; James I Hudson; Brian P Brennan
Journal:  J Obsessive Compuls Relat Disord       Date:  2015-01-01       Impact factor: 1.677

8.  Structure and clinical correlates of obsessive-compulsive symptoms in a large sample of children and adolescents: a factor analytic study across five nations.

Authors:  D R M A Højgaard; E L Mortensen; T Ivarsson; K Hybel; G Skarphedinsson; J B Nissen; R Valderhaug; K Dahl; B Weidle; N C Torp; M Grados; A B Lewin; K H Melin; E A Storch; L H Wolters; T K Murphy; E J S Sonuga-Barke; P H Thomsen
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-07-07       Impact factor: 4.785

9.  Symptom dimensions in obsessive-compulsive disorder as predictors of neurobiology and treatment response.

Authors:  Anders Lillevik Thorsen; Gerd Kvale; Bjarne Hansen; Odile A van den Heuvel
Journal:  Curr Treat Options Psychiatry       Date:  2018-02-23

10.  The associations of obsessive-compulsive symptom dimensions and general severity with suicidal ideation in patients with obsessive-compulsive disorder: The role of specific stress responses to COVID-19.

Authors:  Vahid Khosravani; Seyed Mehdi Samimi Ardestani; Farangis Sharifi Bastan; Dean McKay; Gordon J G Asmundson
Journal:  Clin Psychol Psychother       Date:  2021-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.